Kanad Labs Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 4.00 M
- Company Age 22 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.84 Cr
- Revenue Growth 8.51%
- Profit Growth 251.17%
- Ebitda 51.49%
- Net Worth 3.37%
- Total Assets 9.19%
About Kanad Labs
Kanad Labs Private Limited (KLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 November 2002 and has a history of 22 years and two months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹1.84 Cr.
Ajay Patinge, Girish Waranashiwar, and Girish Borale serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230MH2002PTC138026
-
Company No.
138026
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Nov 2002
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Kanad Labs?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Patinge
|
Director | 02-Dec-2003 | Current |
|
Girish Waranashiwar
|
Director | 13-Jan-2007 | Current |
|
Girish Borale
|
Director | 28-Nov-2002 | Current |
Financial Performance of Kanad Labs.
Kanad Labs Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.51% increase. The company also saw a substantial improvement in profitability, with a 251.17% increase in profit. The company's net worth moved up by a moderate rise of 3.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kanad Labs?
In 2023, Kanad Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹18.37 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.08 Cr
- Icici Bank Limited : 0.44 Cr
- Hdfc Bank Limited : 0.32 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Aug 2022 | Hdfc Bank Limited | ₹0.72 M | Open |
| 25 May 2022 | Hdfc Bank Limited | ₹1.25 M | Open |
| 04 May 2022 | Hdfc Bank Limited | ₹1.25 M | Open |
| 26 May 2016 | Others | ₹0.78 M | Open |
| 16 May 2014 | Icici Bank Limited | ₹4.38 M | Open |
How Many Employees Work at Kanad Labs?
Kanad Labs has a workforce of 44 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kanad Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kanad Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.